Dr. Lucie Low is the Chief Scientist for Axiom Space, where she formulates the strategic research priorities for Axiom Space and advises on the design of Axiom Station to support science and commercial innovation.
She works with global governments, researchers, and industrial partners to develop and grow commercial space economies, and facilitates the development and successful implementation of Axiom Spaceʼs customersʼ and partnersʼ scientific research portfolios. Lucie has 20 years of research experience across academia and government and prior to joining Axiom Space was the Scientific Program Manager for the Tissue Chips for Drug Screening program
and the liaison to NASA at the US National Institutes of Health (NIH).
Lucie received her undergraduate degree from Oxford University in the UK, and holds Masters and PhD degrees in Neuroscience from University College London. She also enjoys skydiving, paragliding, and anything that alters gravityʼs dominance.